A preclinical and phase I clinical study of ex vivo-expanded amyloid beta-specific human regulatory T cells in Alzheimer's disease
| Products/Services Used |
Details |
Operation |
| Recombinant Proteins |
For antigen presentation and inducing Treg expansion, cells were stimulated with aggregated Aβ (1−42), human (Cat. No.: RP10017, GenScript), at a final concentration of 5 µM. These cells are treated with Aβ (1−42), human (Cat. No.: RP10017, GenScript), at a concentration of 5 µM and incubated at 37°C for 6 hours in a 5 % CO2 environment to induce activation. |
Get A Quote |
